Late Cardiovascular Consequences of Gestational Diabetes Mellitus

ABSTRACT

Gestational diabetes mellitus (GDM), defined as carbohydrate intolerance of any degree first recognized during pregnancy, complicates ~4% of all pregnancies in the United States. Several factors can increase one's risk of developing GDM, including obesity, family history of type 2 diabetes mellitus (T2DM), and race/ethnicity. Conversely, a history of GDM can increase the risk of developing not only T2DM but also cardiovascular disease (CVD) independent of a diagnosis of T2DM. Several investigations have explored GDM relationships with CVD risk factors, CVD surrogate markers, and clinically evident CVD. These studies have included evaluations of biochemical parameters, such as inflammatory and endothelial biomarkers; endothelial dysfunction, such as that seen in impaired brachial artery flow-mediated vasodilation; and vascular dysfunction, manifest as cardiac dysfunction or in diseases such as hypertension. This article will review these studies and examine factors considered to be responsible for promoting CVD in women with a history of GDM, such as T2DM and metabolic syndrome and its components. In addition, studies evidencing CVD in women with a history of GDM will be explored.

KEYWORDS

Gestational diabetes mellitus - cardiovascular disease - endothelial dysfunction - inflammation - biomarkers

REFERENCES

• 1 American Diabetes Association . Diagnosis and classification of diabetes mellitus.  Diabetes Care. 2006;  29(Suppl 1) S43-S48
• 2 Berkowitz G S, Lapinski R H, Wein R, Lee D. Race/ethnicity and other risk factors for gestational diabetes.  Am J Epidemiol. 1992;  135 965-973
• 3 Dabelea D, Snell-Bergeon J K, Hartsfield C L, Bischoff K J, Hamman R F, McDuffie R S. Kaiser Permanente of Colorado GDM Screening Program . Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program.  Diabetes Care. 2005;  28 579-584
• 4 Getahun D, Nath C, Ananth C V, Chavez M R, Smulian J C. Gestational diabetes in the United States: temporal trends 1989 through 2004.  Am J Obstet Gynecol. 2008;  198 525.e1-5
• 5 Lawrence J M, Contreras R, Chen W, Sacks D A. Trends in the prevalence of pre-existing diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005.  Diabetes Care. 2008;  31 899-904
• 6 Ogden C L, Carroll M D, Curtin L R, McDowell M A, Tabak C J, Flegal K M. Prevalence of overweight and obesity in the United States, 1999-2004.  JAMA. 2006;  295 1549-1555
• 7 Lu G C, Rouse D J, DuBard M, Cliver S, Kimberlin D, Hauth J C. The effect of the increasing prevalence of maternal obesity on perinatal morbidity.  Am J Obstet Gynecol. 2001;  185 845-849
• 8 Rosenberg T J, Garbers S, Lipkind H, Chiasson M A. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups.  Am J Public Health. 2005;  95 1545-1551
• 9 Verma A, Boney C M, Tucker R, Vohr B R. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus.  J Clin Endocrinol Metab. 2002;  87 3227-3235
• 10 Carpenter M W. Gestational diabetes, pregnancy hypertension, and late vascular disease.  Diabetes Care. 2007;  30(Suppl 2) S246-S250
• 11 Haffner S M, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.  N Engl J Med. 1998;  339 229-234
• 12 Mokdad A H, Ford E S, Bowman B A et al.. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.  JAMA. 2003;  289 76-79
• 13 Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes.  Diabetes Metab Res Rev. 2003;  19 259-270
• 14 Coustan D R, Carpenter M W, O'Sullivan P S, Carr S R. Gestational diabetes: predictors of subsequent disordered glucose metabolism.  Am J Obstet Gynecol. 1993;  168 1139-1144; discussion 1144–1145
• 15 Kjos S L, Peters R K, Xiang A, Henry O A, Montoro M, Buchanan T A. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing.  Diabetes. 1995;  44 586-591
• 16 Kim C, Newton K M, Knopp R H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review.  Diabetes Care. 2002;  25 1862-1868
• 17 Lloyd-Jones D, Adams R, Carnethon M American Heart Association Statistics Committee and Stroke Statistics Subcommittee et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  Circulation. 2009;  119 e21-e181
• 18 Yasuhi I, Hogan J W, Canick J, Sosa M B, Carpenter M W. Midpregnancy serum C-peptide concentration and subsequent pregnancy-induced hypertension.  Diabetes Care. 2001;  24 743-747
• 19 Wolf M, Sandler L, Muñoz K, Hsu K, Ecker J L, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: a prospective study.  J Clin Endocrinol Metab. 2002;  87 1563-1568
• 20 Solomon C G, Seely E W. Hypertension in pregnancy.  Endocrinol Metab Clin North Am. 2006;  35 157-171, vii
• 21 Laivuori H, Tikkanen M J, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy.  J Clin Endocrinol Metab. 1996;  81 2908-2911
• 22 Sibai B M, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis.  Am J Obstet Gynecol. 1986;  155 1011-1016
• 23 Volpe L, Cuccuru I, Lencioni C et al.. Early subclinical atherosclerosis in women with previous gestational diabetes mellitus.  Diabetes Care. 2008;  31 e32
• 24 Bryson C L, Ioannou G N, Rulyak S J, Critchlow C. Association between gestational diabetes and pregnancy-induced hypertension.  Am J Epidemiol. 2003;  158 1148-1153
• 25 Ros H S, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study.  Am J Epidemiol. 1998;  147 1062-1070
• 26 Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures.  JAMA. 1983;  249 2792-2798
• 27 Oren S, Golzman B, Reitblatt T, Turkot S, Kogan J, Segal S. Gestational diabetes mellitus and hypertension in pregnancy: hemodynamics and diurnal arterial pressure profile.  J Hum Hypertens. 1996;  10 505-509
• 28 Toescu V, Nuttall S L, Kendall M J, Martin U, Dunne F. Women with gestational diabetes should be targeted to reduce cardiovascular risk.  BMJ. 2002;  325 966
• 29 Meyers-Seifer C H, Vohr B R. Lipid levels in former gestational diabetic mothers.  Diabetes Care. 1996;  19 1351-1356
• 30 Di Cianni G, Lencioni C, Volpe L et al.. C-reactive protein and metabolic syndrome in women with previous gestational diabetes.  Diabetes Metab Res Rev. 2007;  23 135-140
• 31 Lauenborg J, Mathiesen E, Hansen T et al.. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population.  J Clin Endocrinol Metab. 2005;  90 4004-4010
• 32 Carr D B, Utzschneider K M, Hull R L et al.. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes.  Diabetes Care. 2006;  29 2078-2083
• 33 Noussitou P, Monbaron D, Vial Y, Gaillard R C, Ruiz J. Gestational diabetes mellitus and the risk of metabolic syndrome: a population-based study in Lausanne, Switzerland.  Diabetes Metab. 2005;  31(4 Pt 1) 361-369
• 34 Kim C, Cheng Y J, Beckles G L. Cardiovascular disease risk profiles in women with histories of gestational diabetes but without current diabetes.  Obstet Gynecol. 2008;  112 875-883
• 35 Zouboulis C C. Human skin: an independent peripheral endocrine organ.  Horm Res. 2000;  54 230-242
• 36 Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective.  Endocr Rev. 2001;  22 36-52
• 37 Widlansky M E, Gokce N, Keaney Jr J F, Vita J A. The clinical implications of endothelial dysfunction.  J Am Coll Cardiol. 2003;  42 1149-1160
• 38 Celermajer D S, Sorensen K E, Gooch V M et al.. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.  Lancet. 1992;  340 1111-1115
• 39 Steinberg H O, Chaker H, Leaming R, Johnson A, Brechtel G, Baron A D. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.  J Clin Invest. 1996;  97 2601-2610
• 40 Gokce N, Keaney Jr J F, Hunter L M et al.. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease.  J Am Coll Cardiol. 2003;  41 1769-1775
• 41 Gokce N, Keaney Jr J F, Hunter L M, Watkins M T, Menzoian J O, Vita J A. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study.  Circulation. 2002;  105 1567-1572
• 42 Perticone F, Ceravolo R, Pujia A et al.. Prognostic significance of endothelial dysfunction in hypertensive patients.  Circulation. 2001;  104 191-196
• 43 Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.  Circulation. 2001;  104 2673-2678
• 44 Kousta E, Efstathiadou Z, Lawrence N J et al.. The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes.  Diabetologia. 2006;  49 36-40
• 45 Anastasiou E, Lekakis J P, Alevizaki M et al.. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes.  Diabetes Care. 1998;  21 2111-2115
• 46 Anderson T J, Uehata A, Gerhard M D et al.. Close relation of endothelial function in the human coronary and peripheral circulations.  J Am Coll Cardiol. 1995;  26 1235-1241
• 47 Paradisi G, Biaggi A, Ferrazzani S, De Carolis S, Caruso A. Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction.  Diabetes Care. 2002;  25 560-564
• 48 Hu J, Norman M, Wallensteen M, Gennser G. Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus.  Br J Obstet Gynaecol. 1998;  105 1279-1287
• 49 Bots M L, de Jong P T, Hofman A, Grobbee D E. Left, right, near or far wall common carotid intima-media thickness measurements: associations with cardiovascular disease and lower extremity arterial atherosclerosis.  J Clin Epidemiol. 1997;  50 801-807
• 50 Bots M L, Dijk J M, Oren A, Grobbee D E. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence.  J Hypertens. 2002;  20 2317-2325
• 51 Audelin M C, Genest Jr J. Homocysteine and cardiovascular disease in diabetes mellitus.  Atherosclerosis. 2001;  159 497-511
• 52 Esposito K, Giugliano D, Nappo F, Marfella R. Campanian Postprandial Hyperglycemia Study Group . Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.  Circulation. 2004;  110 214-219
• 53 Tarim E, Yigit F, Kilicdag E et al.. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus.  Ultrasound Obstet Gynecol. 2006;  27 177-182
• 54 Xiang A H, Peters R K, Kjos S L et al.. Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes.  J Clin Endocrinol Metab. 2005;  90 1986-1991
• 55 Xiang A H, Hodis H N, Kawakubo M et al.. Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes.  Atherosclerosis. 2008;  199 207-214
• 56 Pleiner J, Mittermayer F, Langenberger H et al.. Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes.  Wien Klin Wochenschr. 2007;  119 483-489
• 57 Mittermayer F, Mayer B X, Meyer A et al.. Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes.  Diabetologia. 2002;  45 1372-1378
• 58 von Mandach U, Lauth D, Huch R. Maternal and fetal nitric oxide production in normal and abnormal pregnancy.  J Matern Fetal Neonatal Med. 2003;  13 22-27
• 59 Laakso M, Edelman S V, Brechtel G, Baron A D. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.  J Clin Invest. 1990;  85 1844-1852
• 60 Mather K J, Verma S, Anderson T J. Improved endothelial function with metformin in type 2 diabetes mellitus.  J Am Coll Cardiol. 2001;  37 1344-1350
• 61 Watanabe Y, Sunayama S, Shimada K et al.. Troglitazone improves endothelial dysfunction in patients with insulin resistance.  J Atheroscler Thromb. 2000;  7 159-163
• 62 Creager M A, Lüscher T F, Cosentino F, Beckman J A. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.  Circulation. 2003;  108 1527-1532
• 63 Kautzky-Willer A, Fasching P, Jilma B, Waldhäusl W, Wagner O F. Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus.  J Clin Endocrinol Metab. 1997;  82 4117-4121
• 64 Bo S, Valpreda S, Menato G et al.. Should we consider gestational diabetes a vascular risk factor?.  Atherosclerosis. 2007;  194 e72-e79
• 65 Heitritter S M, Solomon C G, Mitchell G F, Skali-Ounis N, Seely E W. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus.  J Clin Endocrinol Metab. 2005;  90 3983-3988
• 66 Di Benedetto A, Russo G T, Corrado F et al.. Inflammatory markers in women with a recent history of gestational diabetes mellitus.  J Endocrinol Invest. 2005;  28 34-38
• 67 Qiu C, Sorensen T K, Luthy D A, Williams M A. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus.  Paediatr Perinat Epidemiol. 2004;  18 377-384
• 68 Retnakaran R, Hanley A J, Raif N, Connelly P W, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity.  J Clin Endocrinol Metab. 2003;  88 3507-3512
• 69 Gasic S, Winzer Ch, Bayerle-Eder M, Roden A, Pacini G, Kautzky-Willer A. Impaired cardiac autonomic function in women with prior gestational diabetes mellitus.  Eur J Clin Invest. 2007;  37 42-47
• 70 Kerényi Z, Stella P, Nádasdi A, Tabák A G, Tamás G. Association between cardiovascular autonomic neuropathy and multimetabolic syndrome in a special cohort of women with prior gestational diabetes mellitus.  Diabet Med. 1999;  16 794-795
• 71 Raffel L J, Robbins D C, Norris J M et al.. The GENNID Study. A resource for mapping the genes that cause NIDDM.  Diabetes Care. 1996;  19 864-872
• 72 Shah B R, Retnakaran R, Booth G L. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus.  Diabetes Care. 2008;  31 1668-1669
• 73 Freire C M, Nunes MdoC, Barbosa M M et al.. Gestational diabetes: a condition of early diastolic abnormalities in young women.  J Am Soc Echocardiogr. 2006;  19 1251-1256
• 74 Bentley-Lewis R, Levkoff S, Stuebe A, Seely E W. Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus.  Nat Clin Pract Endocrinol Metab. 2008;  4 552-558